Physicians at the University of Minnesota and University of Minnesota Children’s Hospital, Fairview have set the path to a cure for a young boy’s fatal genetic skin disease, recessive dystrophic epidermolysis bullosa (RDEB), by using a cord blood and bone marrow transplant. Nate Liao, a 25-month-old from Clarksburg, N.J., underwent the experimental therapy in October 2007.
“We have established a new standard of care for these EB patients, beginning with Nate,” said John Wagner, M.D., the lead University of Minnesota Medical School physician who developed the clinical trial. “Nate’s quality of life is forever changed.”
Because they lack collagen type VII,
A breakthrough was achieved recently in the case of an 18 year old boy, a case of advanced stage of Aplastic anemia where stem cells of not one but three donors were used to treat him. This spectacular feat was achieved by the doctors at The Netaji Subhash Chandra Bose Cancer Research Institute (NSCBCRI) Kolkata.
18 year old Aman, student of class 12, fainted in school. He was diagnosed for Aplastic Anemia, a disorder where the bone marrow stops producing red blood cells and platelets. He was treated in many hospitals, but no amount of blood transfusions or ‘immuno-suppressant’ medication
Patients before and after Regenexx stem cell procedure educational video showing how it is done and patient’s results for knees and hips…
Local News does story on stem cell patient who received the regenexx procedure…
The flattening of the world’s economy has spawned a new trend in the local medical-tourism industry: Foreigners are starting to come to the Philippines because of the country’s ever-growing availability of cheap but reliable regenerative or stem-cell treatments.
Dr. Samuel Bernal, consultant on regenerative medicine for the Medical City, said some hospitals in the Philippines are starting to gain vigor in stem-cell treatments. Patients treated last year reached over 100 in number.
“Ours [Philippines] is cheaper compared to other developed and developing nations,” Bernal told the BusinessMirror in a phone interview on Monday after a briefing with the media on “Bioregenerative
Image by jason | caine via Flickr
A 21-year-old leukemia patient underwent pioneering surgery in a Shanghai hospital Wednesday, when doctors transfused 30 milliliters of umbilical-cord blood donated by a Shanghai cord bank. Today they will transplant a batch of his father’s stem cells, which are an imperfect match.
This combination of umbilical-cord blood and half-matched stem cells can offer lifesaving transplant opportunities to many more patients than traditional methods, which require a perfect match between patient and donor, said doctors from Shanghai No. 1 People’s Hospital.
It will be a month before results of the transplant are determined.
About 40,000 to 50,000